• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Fabiana Gregucci, Roberta Carbonara, and Alba Fiorentino's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.

作者信息

Moris Lisa, Mottet Nicolas, Wiegel Thomas

机构信息

Department of Urology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Molecular Endocrinology, KU Leuven, Leuven, Belgium.

Department of Urology, University Hospital, St. Etienne, France.

出版信息

Eur Urol. 2020 Sep;78(3):e116-e117. doi: 10.1016/j.eururo.2020.05.036. Epub 2020 Jun 11.

DOI:10.1016/j.eururo.2020.05.036
PMID:32536484
Abstract
摘要

相似文献

1
Reply to Fabiana Gregucci, Roberta Carbonara, and Alba Fiorentino's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e116-e117. doi: 10.1016/j.eururo.2020.05.036. Epub 2020 Jun 11.
2
Reply to Satoshi Funada, Takashi Yoshioka, and Yan Luo's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e120-e121. doi: 10.1016/j.eururo.2020.07.005. Epub 2020 Jul 16.
3
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e118-e119. doi: 10.1016/j.eururo.2020.06.057. Epub 2020 Jul 15.
4
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Sep;78(3):e114-e115. doi: 10.1016/j.eururo.2020.05.034. Epub 2020 Jun 10.
5
Re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Eur Urol. 2020 Nov;78(5):e192. doi: 10.1016/j.eururo.2020.07.031. Epub 2020 Aug 13.
6
Reply to Francesco Montorsi, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.对弗朗切斯科·蒙托西、安德里亚·萨洛尼亚和阿尔贝托·布里甘蒂致编辑的信的回复，信的主题为：丽莎·莫里、马库斯·G·坎伯巴奇、托马斯·范登布罗克等人。高危局限性和局部进展性前列腺癌主要治疗方法的获益与风险：一项国际多学科系统评价。《欧洲泌尿外科杂志》2020年；77卷：614 - 27页。
Eur Urol. 2020 Nov;78(5):e193-e194. doi: 10.1016/j.eururo.2020.07.041. Epub 2020 Aug 21.
7
Reply to Fabiana Gregucci and Alba Fiorentino's Letter to the Editor re: Liselotte M.S. Boevé, Maarten C.C.M. Hulshof, André N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomized Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019;75:410-8.
Eur Urol. 2019 May;75(5):e131-e132. doi: 10.1016/j.eururo.2018.12.024. Epub 2019 Jan 4.
8
Reply to Xueliang Zhou and Xinwei Han's Letter to the Editor re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87.回复周雪亮和韩新伟致编辑的信，内容涉及：托马斯·范登布罗克、罗德里克·C·N·范登伯格、尼古拉斯·阿尔菲等人。前列腺癌根治性治疗后生化复发的预后价值：一项系统评价。《欧洲泌尿外科杂志》2019年；75卷：967 - 87页。
Eur Urol. 2019 Jul;76(1):e16. doi: 10.1016/j.eururo.2019.03.027. Epub 2019 Apr 6.
9
Re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87.回复：托马斯·范登布罗克、罗德里克·C·N·范登伯格、尼古拉斯·阿尔菲等。前列腺癌根治性治疗后生化复发的预后价值：一项系统评价。《欧洲泌尿外科杂志》2019年；75卷：967 - 87页。
Eur Urol. 2019 Jul;76(1):e15. doi: 10.1016/j.eururo.2019.03.028. Epub 2019 Apr 1.
10
Reply to Thomas Van den Broeck, R. Jeffrey Karnes, and Steven Joniau's Letter to the Editor re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766-73.对托马斯·范登·布罗克、R.杰弗里·卡恩斯和史蒂文·乔尼奥的致编辑信的回复，信的内容涉及阿马尔·U.基尚、塔尔哈·谢赫、平杰·王等人的《接受放疗或根治性前列腺切除术的 Gleason 评分 9 - 10 前列腺腺癌患者的临床结局：多机构比较分析》。《欧洲泌尿外科杂志》2017 年；71:766 - 73。
Eur Urol. 2017 Nov;72(5):e123-e124. doi: 10.1016/j.eururo.2017.01.017. Epub 2017 Jan 19.